- ICH GCP
- US Clinical Trials Registry
- Search trials
Search clinical trials for: T790M mutation
Total 3285 results
-
Pusan National University HospitalRecruitingNon Small Cell Lung Cancer | EGFR Gene MutationKorea, Republic of
-
Shanghai EpimAb Biotherapeutics Co., Ltd.Labcorp Corporation of America Holdings, IncNot yet recruitingMetastatic Lung Non-Small Cell Carcinoma | Stage IVA Lung Cancer AJCC v8 | Stage IVB Lung Cancer AJCC v8 | Stage III Lung Cancer AJCC v8 | Stage IV Lung Cancer AJCC v8 | Stage IIIA Lung Cancer AJCC v8 | Stage IIIB Lung Cancer AJCC v8 | Advanced Lung Non-Small Cell Carcinoma | EGFR Mutation-Related TumorsUnited States, China
-
N.N. Blokhin National Medical Research Center of...RecruitingNon Small Cell Lung Cancer | EGFR Gene Mutation | T790MRussian Federation
-
National Cancer Institute (NCI)CompletedLung Neoplasms | Lung AdenocarcinomaUnited States
-
Novartis PharmaceuticalsTerminatedCarcinoma, Non-Small-Cell LungJapan, Korea, Republic of, Singapore
-
Novartis PharmaceuticalsActive, not recruitingEGFR-mutant Non-small Cell Lung CancerTaiwan, Germany, Canada, Italy, Singapore, Hong Kong
-
AstraZenecaCompletedAdvanced Non Small Cell Lung Cancer | Advanced (Inoperable) Non Small Cell Lung CancerUnited States, France, Germany, Korea, Republic of, Taiwan, United Kingdom, Spain, Italy, Japan, Australia
-
Blueprint Medicines CorporationActive, not recruitingNeoplasms | Neoplasms by Histologic Type | Lung Diseases | Neoplasms by Site | Adenocarcinoma | Carcinoma | Carcinoma, Non-Small-Cell Lung | Lung Neoplasms | Respiratory Tract Neoplasms | Thoracic Neoplasms | Carcinoma, Bronchogenic | Bronchial Neoplasms | Neoplasms, Nerve Tissue | EGF-R Positive Non-Small Cell Lung... and other conditionsUnited States, Canada, Taiwan, Korea, Republic of, Singapore, Japan, United Kingdom, France, Netherlands, Spain
-
AstraZenecaCompletedNon Small Cell Lung CancerItaly, United States, Canada, Korea, Republic of, Japan, Taiwan, Hong Kong, Spain
-
Thoraxklinik-Heidelberg gGmbHAstraZenecaCompletedEGFR Positive Non-small Cell Lung CancerGermany
-
AstraZenecaActive, not recruitingAnticancer TreatmentUnited States, France, Germany, Spain, Sweden, United Kingdom, Canada, Italy, Korea, Republic of, Hungary, Japan, Russian Federation, China, Taiwan, Hong Kong, Netherlands, Australia, Mexico
-
Novartis PharmaceuticalsCompletedAdvanced Non-small Cell Lung CancerSpain, Canada, Germany, Korea, Republic of, Taiwan, United States, Japan, Netherlands, Singapore
-
Shanghai Junshi Bioscience Co., Ltd.Completed
-
Yuhan CorporationCompleted
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR T790M+ NSCLCCanada, Korea, Republic of, Taiwan
-
Michael HoppBoehringer IngelheimActive, not recruiting
-
G1 Therapeutics, Inc.CompletedCarcinoma, Non-Small-Cell Lung | Lung Cancer | Non-small Cell Lung CancerUnited States
-
Sihuan Pharmaceutical Holdings Group Ltd.TerminatedNon Small Cell Lung CancerChina
-
AstraZenecaActive, not recruitingNon-Small Cell Lung CancerKorea, Republic of, China, Australia
-
Checkpoint Therapeutics, Inc.CompletedLung Diseases | Adenocarcinoma | Carcinoma, Non-Small-Cell Lung | Lung NeoplasmsUnited States, Thailand, New Zealand, Australia, Poland
-
Sunshine Lake Pharma Co., Ltd.Active, not recruitingNon-small Cell Lung CancerChina
-
Fundación GECPCompletedNon Small Cell Lung CancerSpain
-
Beta Pharma ShanghaiCompleted
-
Beta Pharma ShanghaiCompletedNon-small Cell Lung CancerChina
-
AstraZenecaParexelCompletedLung CancerCanada, Denmark, Italy, Spain, Belgium, Korea, Republic of, Brazil, China, Taiwan, Australia, Austria, United Kingdom, Sweden, Argentina, Saudi Arabia, Ireland
-
Exosome Diagnostics, Inc.Active, not recruitingCarcinoma, Non-Small-Cell LungUnited States
-
Samsung Medical CenterActive, not recruitingNon-Small Cell Lung Cancer With EGFR T790M Mutation | With Brain and/or Leptomeningeal Metastasis | Failed Tyrosine Kinase InhibitorsKorea, Republic of
-
Yuhan CorporationActive, not recruitingEGFR Gene MutationKorea, Republic of
-
PfizerTerminatedNon-Small Cell Lung CancerUnited States, Korea, Republic of, Australia, Japan
-
AstraZenecaiOMEDICO AG, Freiburg, GermanyCompletedCarcinoma, Non-Small-Cell LungGermany
-
Hanmi Pharmaceutical Company LimitedTerminatedNon Small Cell Lung CancerUnited States, Australia, Italy, Korea, Republic of, Spain, Germany, Malaysia, Taiwan, Canada, Philippines
-
H. Lee Moffitt Cancer Center and Research InstituteBristol-Myers Squibb; Boehringer IngelheimCompletedLung Cancer | Non-small Cell Lung Cancer (NSCLC)United States
-
Fudan UniversityUnknownLung Cancer, Non-small Cell | EGFR Gene Mutation | EGFR T790MChina
-
Guangzhou Institute of Respiratory DiseaseShanghai Junshi Bioscience Co., Ltd.UnknownIIIb/IV NSCLC With T790M Positive Mutations Failed to Osimertinib TherapyChina
-
The First Hospital of Jilin UniversityUnknownNon Small Cell Lung CancerChina
-
Spanish Lung Cancer GroupCompleted
-
Haihe Biopharma Co., Ltd.UnknownNegative T790M Mutation and Met AmplificationChina
-
Astellas Pharma Global Development, Inc.CompletedNon-Small-Cell Lung Cancer (NSCLC) | Epidermal Growth Factor Receptor MutationsUnited States
-
AstraZenecaMedpace, Inc.CompletedNon-small Cell Lung CancerUnited States, Canada
-
Astellas Pharma IncTerminatedNon-small Cell Lung CancerJapan, Korea, Republic of, Taiwan
-
Konkuk University Medical CenterHanmi Pharmaceutical Company LimitedCompletedNon Small Cell Lung CancerKorea, Republic of
-
Betta Pharmaceuticals Co., Ltd.CompletedNon-Small Cell Lung CancerChina
-
AstraZenecaCompletedLocally Advanced or Metastatic EGFR(+) NSCLC PatientsChina
-
AstraZenecaWithdrawnNon-small Cell Lung Cancer
-
National University Hospital, SingaporeAstraZeneca; Singapore Clinical Research InstituteUnknownCarcinoma, Non-Small-Cell LungTaiwan, Hong Kong, Thailand, Singapore, Korea, Republic of
-
First People's Hospital of HangzhouCompletedNon-small Cell Lung Cancer Stage III | Non-Small-Cell Lung Cancer MetastaticChina
-
Qingdao Central HospitalCompletedProgression Free SurvivalChina
-
AstraZenecaTerminatedCarcinoma, Non-Small-Cell LungFrance, Spain, United Kingdom, China, Canada, Taiwan
-
PfizerCompletedNon-small Cell Lung CancerKorea, Republic of, United States
-
Boehringer IngelheimCompletedCarcinoma, Non-Small-Cell LungUnited States